Hossein Khiabanian
Rutgers, The State University of New Jersey
H-index: 38
North America-United States
Top articles of Hossein Khiabanian
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Therapeutic targeting of ACLY in T-ALL in vivo | bioRxiv | Victoria da Silva-Diz Amartya Singh Olga Lancho Maya Aleksandrova Komal Mandleywala | 2023/3/28 |
Feature selection followed by a residuals-based normalization simplifies and improves single-cell gene expression analysis | bioRxiv | Amartya Singh Hossein Khiabanian | 2023/3/3 |
A Therapeutically Targetable NOTCH1–SIRT1–KAT7 Axis in T-cell Leukemia | Blood cancer discovery | Olga Lancho Amartya Singh Victoria da Silva-Diz Maya Aleksandrova Jesminara Khatun | 2023/1/6 |
Error-prone repair of stalled replication forks drives mutagenesis and loss of heterozygosity in haploinsufficient BRCA1 cells | Molecular cell | Madhura Deshpande Theodore Paniza Nahed Jalloul Gouri Nanjangud Jerzy Twarowski | 2022/10/20 |
Super-enhancer hypermutation alters oncogene expression in B cell lymphoma | Nature | Elodie Bal Rahul Kumar Mohammad Hadigol Antony B Holmes Laura K Hilton | 2022/7 |
Reply to T. Ménard. Inferences of Mutational Status for Variants Detected from Tumor-Only Sequencing–A Quality Assurance Strategy | JCO Precision Oncology | Nahed Jalloul Shridar Ganesan Judy E Garber Hossein Khiabanian | 2022/6/1 |
Computational structure prediction methods enable the systematic identification of oncogenic mutations | bioRxiv | Xi Fu Clara Reglero Vinay Swamy Jui Wan Loh Hossein Khiabanian | 2022/11/20 |
Gene expression of adipokines and adipokine receptors in the tumor microenvironment: Associations of lower expression with more aggressive breast tumor features | Breast cancer research and treatment | Adana AM Llanos Song Yao Amartya Singh John B Aremu Hossein Khiabanian | 2021/2 |
Cilium Expression Score Predicts Glioma Survival | Frontiers in genetics | Srinivas Rajagopalan Amartya Singh Hossein Khiabanian | 2021/11 |
Spleen plays a major role in DLL4-driven acute T-cell lymphoblastic leukemia | Theranostics | Huizhong Xiong Maicol Mancini Michael Gobert Shiqian Shen Glaucia C Furtado | 2021 |
Genetic and Phenotypic Attributes of Splenic Marginal Zone Lymphoma | Blood | Ferdinando Bonfiglio Alessio Bruscaggin Francesca Guidetti Lodovico Terzi di Bergamo Martin Faderl | 2021/10/19 |
A Tumor Suppressor Enhancer of PTEN in T-cell Development and Leukemia | Blood cancer discovery | Luca Tottone Olga Lancho Jui-Wan Loh Amartya Singh Shunsuke Kimura | 2021/1/1 |
A novel and highly effective mitochondrial uncoupling drug in T-cell leukemia | Blood, The Journal of the American Society of Hematology | Victoria da Silva-Diz Bin Cao Olga Lancho Eric Chiles Amer Alasadi | 2021/10/14 |
Pervasive hypermutation of super‐enhancer regions dysregulates oncogene expression in diffuse large B‐cell lymphoma | Hematological Oncology | E Bal R Kumar M Hadigol A Holmes K Basso | 2021/6 |
JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistance | Hatem E Sabaawy Bríd M Ryan Hossein Khiabanian Sharon R Pine | 2021/12/1 | |
Adaptation of chronic lymphocytic leukemia to ibrutinib is mediated by epigenetic plasticity of residual disease and by‐pass signaling via MAPK pathway | Hematological Oncology | L Terzi di Bergamo G Forestieri JW Loh A Singh V Spina | 2021/6 |
Germline testing data validate inferences of mutational status for variants detected from tumor-only sequencing | JCO Precision Oncology | Nahed Jalloul Israel Gomy Samantha Stokes Alexander Gusev Bruce E Johnson | 2021/11 |
Tissue-and development-stage–specific mRNA and heterogeneous CNV signatures of human ribosomal proteins in normal and cancer samples | Nucleic acids research | Anshuman Panda Anupama Yadav Huwate Yeerna Amartya Singh Michael Biehl | 2020/7/27 |
Pan-Cancer Analysis of BRCA1 and BRCA2 Genomic Alterations and Their Association With Genomic Instability as Measured by Genome-Wide Loss of … | JCO precision oncology | Ethan S Sokol Dean Pavlick Hossein Khiabanian Garrett M Frampton Jeffrey S Ross | 2020/4 |
Subclonal NT5C2 mutations are associated with poor outcomes after relapse of pediatric acute lymphoblastic leukemia | Blood, The Journal of the American Society of Hematology | Malwine J Barz Jana Hof Stefanie Groeneveld-Krentz Jui Wan Loh Annabell Szymansky | 2020/3/19 |
Co-Authors
